Health Happenings—Convention This Weekend To Focus On Alternative Cancer Treatments
Pictured: Resident Earl Mindell, R.Ph., Ph.D., will speak on the topic, “Cancer Doesn’t Live Here Anymore.”
The latest breakthrough information toward the prevention and control of cancer through nutrition, tests and non-toxic Alternative Therapies, will be highlighted at the 42nd annual Cancer Convention from 9 a.m.-9 p.m. each day, over Labor Day weekend, Aug. 30-Sept. 1 at the Sheraton Universal Hotel, 333 Universal Hollywood Dr.
Sponsored by the Cancer Control Society, an educational non-profit, the event will feature more than 40 speakers from the fields of nutrition and holistic medicine, 80 exhibits and five movies. Many recovered cancer patients will also attend and tell their success stories.
• Among the speakers is longtime Beverly Hills resident Earl Mindell, R.Ph., Ph.D. on the topic, “Cancer Doesn’t Live Here Anymore.”
Additional speakers include: Bradford Weeks, M.D., “Inflammation & Cancer;” Patrick Quillin, author of Beating Cancer With Nutrition and Peter Starr, with the topic, “Options For Surviving Prostate Cancer.”
Doctors, clinical researchers, nutritionists and authors will speak on prevention and control of cancer and other diseases through such therapies as Gerson, Hoxsey, Poly-MVA, Phytochemicals and more.
Featured movies to be screened include: What Your Doctor Won’t Tell You About Cancer, narrated by the late Eddie Albert, and Cancer: The Forbidden Cures.
• The conference will also be a chance to get a sneak peak at Second Opinion: Laetrile At Sloan-Kettering.
Eric Merola’s documentary, that tells the true story of a young science-writer at Memorial Sloan-Kettering Cancer Center, who risked everything by blowing the whistle on a massive cover-up involving a promising cancer therapy opens for a limited run at Beverly Hills’ Laemmle’s Music Hall, 9036 Wilshire Blvd., on Friday, Sept. 5.
Second Opinion depicts The War On Cancer, launched in the early 1970s, which set the stage for a massive influx of new ideas in fighting the disease. Memorial Sloan-Kettering, America’s leading cancer research center at the time, was assigned the task of testing an unconventional therapy called “Laetrile” in an effort to curb the public’s “false hope” in the alleged “quack” therapy.
Ralph W. Moss PhD, a young and eager science writer, was hired by Sloan-Kettering’s public relations department in 1974 to help brief the American public on the center’s contribution to the War On Cancer. One of his first assignments was to write a biography about Dr. Kanematsu Sugiura, one of the center’s oldest and leading research scientists as well as the original co-inventor of chemotherapy.
Meeting with this iconic scientist to pen a biography on his 60-year career at Sloan-Kettering, Moss discovered that Sugiura had been studying this “quack remedy” in laboratory mice with unexpectedly positive results.
Shocked and bewildered, Moss reported back to his superiors what he had discovered, only to be met with backlash and denial from Sloan-Kettering’s leaders on what their own leading scientist had found.
Fueled by respect and admiration for Sugiura—Moss attempted to publicize the truth about Sugiura’s findings. And after all diplomatic approaches failed, Moss started living a double life, working as a loyal employee at Sloan-Kettering while also recruiting fellow employees to help anonymously leak this information to the American public—through a newly formed underground organization they called—“Second Opinion.”
Moss is the author of The Cancer Industry. His latest book, Doctored Results was released in February.
As a medical writer, Moss has written 15 books on questions relating to cancer research and treatment. For the past 35 years Moss has independently evaluated the claims of conventional and non-conventional cancer treatments.
In 1994, Moss was formally invited by Harold Varmus, MD—the director of America’s National Institute’s of Health (NIH)—to be a member of the NIH’s Alternative Medicine Advisory Council where he became a co-founding advisor to the NIH’s Office Of Alternative Medicine (now NCCAM).
• A Doctor’s Symposium from 10 a.m.-5 p.m., Tuesday, Sept. 2 is $75 (including lunch) and open to the public. The seminar is approved for six hours of CE credits for nurses and dentists.
Admission for the convention is $40 per day. For more information and doctor referrals, call CCS, 323-663-7801 or 7805. To learn more about the society, visit its website, www.CancerControlSociety.com.